Tyra Biosciences, Inc. TYRA Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $84.96M+9.8% | $77.39M+24.9% | $61.95M-37.1% | $98.49M-2.2% | $100.72M+9.5% | ||
| $884K-11.6% | $1M0.0% | $1M0.0% | $1M0.0% | $1M0.0% | ||
| $11.15M+18.0% | $9.45M+50.1% | $6.29M+6.9% | $5.88M+4.6% | $5.62M-6.6% | ||
| $394.61M+48.7% | $265.45M-5.6% | $281.22M-6.9% | $302.16M-6.9% | $324.57M-6.6% | ||
| $1.22M-7.5% | $1.31M-2.4% | $1.35M-4.7% | $1.41M-7.2% | $1.52M-7.8% | ||
| $9.89M+6.6% | $9.27M-26.4% | $12.59M+13.3% | $11.11M+6.4% | $10.44M+41.6% | ||
| $412.04M+45.8% | $282.61M-6.4% | $301.85M-6.1% | $321.5M-6.4% | $343.48M-5.5% | ||
| $3.64M+209% | $1.18M-40.8% | $1.99M-11.3% | $2.25M-10.2% | $2.5M+324% | ||
| $15.13M-8.0% | $16.44M+22.4% | $13.43M+21.2% | $11.08M-2.1% | $11.32M-16.7% | ||
| $488K+3.4% | $472K+3.5% | $456K+3.4% | $441K+3.5% | $426K+3.4% | ||
| $19.26M+6.4% | $18.09M+13.9% | $15.88M+15.3% | $13.77M-3.3% | $14.25M-2.4% | ||
| $5.21M-2.4% | $5.34M-2.3% | $5.46M-2.1% | $5.58M-2.0% | $5.7M-2.0% | ||
| $5.7M-1.9% | $5.81M-1.8% | $5.92M-1.7% | $6.02M-1.6% | $6.12M-1.6% | ||
| $24.47M+4.4% | $23.43M+9.8% | $21.34M+10.3% | $19.35M-3.0% | $19.94M-2.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $6K+20.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| $798.03M+26.7% | $630.04M+2.0% | $617.49M+1.3% | $609.26M+1.2% | $602.3M+1.5% | ||
| -$410.56M-10.6% | -$371.26M-10.0% | -$337.42M-9.7% | -$307.56M-10.1% | -$279.46M-11.2% | ||
| $107K-72.8% | $393K-11.1% | $442K+1.4% | $436K-36.6% | $688K-10.6% | ||
| $387.58M+49.5% | $259.18M-7.6% | $280.51M-7.2% | $302.15M-6.6% | $323.53M-5.7% | ||
| $412.04M+45.8% | $282.61M-6.4% | $301.85M-6.1% | $321.5M-6.4% | $343.48M-5.5% | ||
| $9.89M+6.6% | $9.27M-26.4% | $12.59M+13.3% | $11.11M+6.4% | $10.44M+41.6% | ||
| $9.89M+6.6% | $9.27M-26.4% | $12.59M+13.3% | $11.11M+6.4% | $10.44M+41.6% | ||
| $5.44M-2.3% | $5.57M-2.2% | $5.7M-2.1% | $5.82M-2.1% | $5.95M-2.0% | ||
| $9.89M+6.6% | $9.27M-26.4% | $12.59M+13.3% | $11.11M+6.4% | $10.44M+41.6% | ||
| $5.7M-1.9% | $5.81M-1.8% | $5.92M-1.7% | $6.02M-1.6% | $6.12M-1.6% | ||
| $798.03M+26.7% | $630.04M+2.0% | $617.49M+1.3% | $609.26M+1.2% | $602.3M+1.5% | ||
| $6K+20.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $15.13M-8.0% | $16.44M+22.4% | $13.43M+21.2% | $11.08M-2.1% | $11.32M-16.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tyra Biosciences, Inc.'s total assets?
- Tyra Biosciences, Inc. (TYRA) holds $412.0M in total assets, up 20.0% year over year.
- How much debt does Tyra Biosciences, Inc. have?
- Tyra Biosciences, Inc. carries $5.7M in total debt against $387.6M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Tyra Biosciences, Inc. have?
- Tyra Biosciences, Inc. holds $85.0M in cash and equivalents.
- Can Tyra Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 20.49 — current assets exceed current liabilities.
- Where does Tyra Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.